Skip to content
10-Q

Quarterly Report

ACCUSTEM SCIENCES, INC. ACUT

0001493152-26-023742

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 15, 2026 16.07M sh
Shares Diluted Q1 2026 · Mar 31, 2026 16.07M sh
Shares Diluted Q1 2026 · Mar 31, 2025 12.72M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$374.18K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$290.18K
Stockholders Equity Q1 2026 · Mar 31, 2026 −$3.87M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$3.4M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$2.16M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$3.31M
Current Liabilities Q1 2026 · Mar 31, 2026 $5.42M
Current Liabilities Q1 2026 · Dec 31, 2025 $4.95M
Total Liabilities Q1 2026 · Mar 31, 2026 $5.42M
Total Liabilities Q1 2026 · Dec 31, 2025 $4.95M
Current Assets Q1 2026 · Mar 31, 2026 $49.53K
Current Assets Q1 2026 · Dec 31, 2025 $49.45K
Total Assets Q1 2026 · Mar 31, 2026 $1.55M
Total Assets Q1 2026 · Dec 31, 2025 $1.55M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.03
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.03
Eps Basic Q1 2026 · Mar 31, 2026 −$0.03
Eps Basic Q1 2026 · Mar 31, 2025 −$0.03
Sga Expense Q1 2026 · Mar 31, 2026 $366.36K
Sga Expense Q1 2026 · Mar 31, 2025 $412.06K
Rd Expense Q1 2026 · Mar 31, 2026 $119.53K
Rd Expense Q1 2026 · Mar 31, 2025 $28.35K
Net Income Q1 2026 · Mar 31, 2026 −$485.88K
Net Income Q1 2026 · Mar 31, 2025 −$440.41K
Operating Income Q1 2026 · Mar 31, 2026 −$485.88K
Operating Income Q1 2026 · Mar 31, 2025 −$440.41K